Taiwan Liposome Statistics Share Statistics Taiwan Liposome has n/a
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 5.62K, so 0% of the outstanding
shares have been sold short.
Short Interest 5.62K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -4.97 and the forward
PE ratio is null.
Taiwan Liposome's PEG ratio is
-4.9.
PE Ratio -4.97 Forward PE n/a PS Ratio 47.99 Forward PS n/a PB Ratio 11.17 P/FCF Ratio -5.38 PEG Ratio -4.9
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Taiwan Liposome.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.11,
with a Debt / Equity ratio of 1.52.
Current Ratio 4.11 Quick Ratio 4.11 Debt / Equity 1.52 Debt / EBITDA -0.73 Debt / FCF -0.73 Interest Coverage -60.12
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0.06 Inventory Turnover n/a
Taxes Income Tax 1.13M Effective Tax Rate -0.12%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.8, so Taiwan Liposome's
price volatility has been higher than the market average.
Beta 0.8 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) n/a Average Volume (20 Days) 17,612
Income Statement In the last 12 months, Taiwan Liposome had revenue of 101.93M
and earned -983.31M
in profits. Earnings per share was -24.89.
Revenue 101.93M Gross Profit 101.93M Operating Income -983.11M Net Income -983.31M EBITDA -909.66M EBIT -965.82M Earnings Per Share (EPS) -24.89
Full Income Statement Balance Sheet The company has 1.34B in cash and 667.38M in
debt, giving a net cash position of 675.28M.
Cash & Cash Equivalents 1.34B Total Debt 667.38M Net Cash 675.28M Retained Earnings -2.7B Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -875.19M
and capital expenditures -34.38M, giving a free cash flow of -909.57M.
Operating Cash Flow -875.19M Capital Expenditures -34.38M Free Cash Flow -909.57M FCF Per Share -23.02
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -964.51% and -964.71%.
Gross Margin 100% Operating Margin -964.51% Pretax Margin -963.6% Profit Margin -964.71% EBITDA Margin -892.45% EBIT Margin -964.51% FCF Margin -892.36%
